Kyohei Yamada Selected Research

Kyohei Yamada Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 09/2008
9	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2023 - 01/2019
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 11/2018
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2024 - 01/2018
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2022 - 11/2018
3	Rheumatoid Arthritis 01/2019 - 01/2011
2	Lymphoma (Lymphomas) 01/2023 - 02/2018
2	Carcinoma (Carcinomatosis) 10/2021 - 01/2019
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 11/2018
2	Arthritis (Polyarthritis) 01/2011 - 10/2010
2	Experimental Arthritis 01/2011 - 10/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Myeloid Sarcoma (Chloroma) 11/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2022
1	Pseudolymphoma 10/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Necrosis 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Extranodal NK-T-Cell Lymphoma 02/2018
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Osteoarthritis 06/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2020
4	Immune Checkpoint ProteinsIBA 12/2023 - 11/2018
3	CytokinesIBA 01/2024 - 10/2010
3	RNA (Ribonucleic Acid)IBA 05/2019 - 01/2019
3	SmokeIBA 06/2013 - 10/2010
2	Hematoxylin (Haematoxylon)IBA 01/2023 - 10/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2023 - 10/2020
2	B7-H1 AntigenIBA 10/2022 - 11/2018
2	Brentuximab VedotinIBA 11/2021 - 02/2018
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 11/2018
2	Freund's AdjuvantIBA 01/2011 - 10/2010
2	CollagenIBA 01/2011 - 10/2010
2	Collagen Type II (Type II Collagen)IBA 01/2011 - 10/2010
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 01/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	TetraspaninsIBA 05/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2022
1	ParaffinIBA 04/2022
1	Immunoglobulin G (IgG)IBA 04/2022
1	Rituximab (Mabthera)FDA Link 11/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	LigandsIBA 05/2020
1	AntibodiesIBA 05/2020
1	GlucocorticoidsIBA 05/2020
1	Immunoglobulins (Immunoglobulin)IBA 05/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2020
1	OX40 LigandIBA 05/2020
1	4-1BB Ligand (4 1BB Ligand)IBA 05/2020
1	Mucin-3IBA 05/2020
1	mogamulizumabIBA 08/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2013
1	NF-kappa B (NF-kB)IBA 06/2013
1	Monocyclic SesquiterpenesIBA 09/2008
1	SesquiterpenesIBA 09/2008
1	3,6-epidioxy-1,10-bisaboladieneIBA 09/2008

Therapy/Procedure

2	Therapeutics 01/2019 - 02/2018
1	Nephrectomy 01/2024
1	Intraperitoneal Injections 01/2011
1	Subcutaneous Injections 01/2011